| Code | Description | Claims | Beneficiaries | Total Paid |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
4,534 |
4,530 |
$2.52M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
15,652 |
15,339 |
$1.53M |
| 81329 |
|
4,530 |
4,525 |
$580K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
14,544 |
14,531 |
$504K |
| 88307 |
|
4,046 |
4,012 |
$454K |
| 81243 |
|
4,503 |
4,503 |
$259K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
5,844 |
5,837 |
$202K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
5,842 |
5,835 |
$202K |
| 88342 |
|
3,136 |
3,010 |
$188K |
| 88341 |
|
989 |
913 |
$187K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
4,369 |
4,364 |
$149K |
| 83020 |
|
7,387 |
7,353 |
$143K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
3,812 |
3,808 |
$96K |
| 88141 |
|
1,899 |
1,898 |
$53K |
| 84165 |
|
3,804 |
3,553 |
$50K |
| 88112 |
|
1,056 |
1,000 |
$37K |
| 86334 |
|
2,707 |
2,509 |
$37K |
| 88173 |
|
210 |
194 |
$33K |
| 88304 |
|
2,268 |
2,255 |
$33K |
| 84166 |
|
1,663 |
1,564 |
$23K |
| 88360 |
|
196 |
193 |
$21K |
| 86335 |
|
1,037 |
975 |
$15K |
| 88313 |
|
149 |
138 |
$11K |
| 81401 |
|
69 |
69 |
$10K |
| 88312 |
|
155 |
139 |
$9K |
| 88350 |
|
25 |
24 |
$5K |
| 88365 |
|
21 |
20 |
$2K |
| 88189 |
|
26 |
24 |
$2K |
| 88302 |
|
169 |
169 |
$2K |
| 88364 |
|
15 |
14 |
$2K |
| 88142 |
|
97 |
97 |
$2K |
| 88300 |
|
273 |
270 |
$2K |
| 88346 |
|
26 |
24 |
$2K |
| 88311 |
|
101 |
98 |
$1K |
| 86077 |
|
15 |
12 |
$879.15 |
| 99080 |
|
456 |
259 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
28 |
12 |
$0.00 |